293 related articles for article (PubMed ID: 18324894)
21. HIV-1 vaccine clinical trials: the Brazilian experience.
Ersching J; Pinto AR
Rev Med Virol; 2009 Sep; 19(5):301-11. PubMed ID: 19650156
[TBL] [Abstract][Full Text] [Related]
22. HIV vaccine development and clinical trials.
Hoff R; McNamara J; Fowler M; McCauley M
Acta Paediatr Suppl; 1994 Aug; 400():73-7. PubMed ID: 7833567
[TBL] [Abstract][Full Text] [Related]
23. Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults.
Durier C; Launay O; Meiffrédy V; Saïdi Y; Salmon D; Lévy Y; Guillet JG; Pialoux G; Aboulker JP
AIDS; 2006 Apr; 20(7):1039-49. PubMed ID: 16603857
[TBL] [Abstract][Full Text] [Related]
24. Paralysis in AIDS vaccine development violates ethical principles and human rights.
Mann JM
J Int Assoc Physicians AIDS Care; 1998 May; 4(5):42-3. PubMed ID: 11365188
[TBL] [Abstract][Full Text] [Related]
25. Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.
Han J; Wang L; Jiang Y; Zhang Q; Fang L; Yao J; Wang Q
Int J STD AIDS; 2009 Apr; 20(4):249-54. PubMed ID: 19304969
[TBL] [Abstract][Full Text] [Related]
26. [HIV infection in women in childbearing age].
Olczak A; Grabczewska E; Fórmaniak J
Przegl Epidemiol; 2008; 62(4):785-92. PubMed ID: 19209741
[TBL] [Abstract][Full Text] [Related]
27. Global HIV cohort studies among injecting drug users and future vaccine trials.
Woratanarat T
J Med Assoc Thai; 2006 Jul; 89(7):1064-79. PubMed ID: 16881444
[TBL] [Abstract][Full Text] [Related]
28. Reducing HIV infection and abandonment of babies.
Cohen J
Science; 2010 Jul; 329(5988):172. PubMed ID: 20616268
[No Abstract] [Full Text] [Related]
29. HIV vaccine research in Thailand: lessons learned.
Pitisuttithum P
Expert Rev Vaccines; 2008 Apr; 7(3):311-7. PubMed ID: 18393601
[TBL] [Abstract][Full Text] [Related]
30. Preparations for AIDS vaccine trials. Recruitment and retention of in- and out-of-treatment injection drug users.
Woody GE; Metzger D; Mulvaney F
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S197-9. PubMed ID: 7865300
[No Abstract] [Full Text] [Related]
31. A small dose of HIV? HIV vaccine mental models and risk communication.
Newman PA; Seiden DS; Roberts KJ; Kakinami L; Duan N
Health Educ Behav; 2009 Apr; 36(2):321-33. PubMed ID: 18032589
[TBL] [Abstract][Full Text] [Related]
32. HIV/AIDS vaccines: a need for new concepts?
Girard MP; Bansal GP
Int Rev Immunol; 2008; 27(6):447-71. PubMed ID: 19065351
[TBL] [Abstract][Full Text] [Related]
33. Correlates of HIV vaccine trial participation: an Indian perspective.
Sahay S; Mehendale S; Sane S; Brahme R; Brown A; Charron K; Beyrer C; Bollinger R; Paranjape R
Vaccine; 2005 Feb; 23(11):1351-8. PubMed ID: 15661383
[TBL] [Abstract][Full Text] [Related]
34. Social impact of preventive HIV vaccine clinical trial participation: a model of prevention, assessment and intervention.
Allen M; Lau CY
Soc Sci Med; 2008 Feb; 66(4):945-51. PubMed ID: 18162272
[TBL] [Abstract][Full Text] [Related]
35. Relative versus absolute standards for everyday risk in adolescent HIV prevention trials: expanding the debate.
Snyder J; Miller CL; Gray G
Am J Bioeth; 2011 Jun; 11(6):5-13. PubMed ID: 21678205
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus vaccine development in developing countries: are efficacy trials feasible?
Excler JL; Beyrer C
J Hum Virol; 2000; 3(4):193-214. PubMed ID: 10990167
[TBL] [Abstract][Full Text] [Related]
37. Prevention of human immunodeficiency virus mother-to-child transmission in Israel.
Agmon-Levin N; Elbirt D; Asher I; Torten D; Cohen Y; Gradestein S; Werner B; Turner D; Chowers M; Gottesman G; Maayan S; Risenberg K; Levi I; Sthoeger Z
Int J STD AIDS; 2009 Jul; 20(7):473-6. PubMed ID: 19541889
[TBL] [Abstract][Full Text] [Related]
38. Pregnancy in perinatally HIV-infected adolescents.
Levine AB; Aaron E; Foster J
J Adolesc Health; 2006 Jun; 38(6):765-8. PubMed ID: 16730612
[TBL] [Abstract][Full Text] [Related]
39. [Maternal-fetal transmission of HIV and after care of infants in pediatrics].
Monpoux F; Soumah M; Falzon C; Cozzi P
Soins; 2009 Apr; (734):45-6. PubMed ID: 19475829
[No Abstract] [Full Text] [Related]
40. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
